Sökning: id:"swepub:oai:DiVA.org:uu-79047" >
Enhanced interleuki...
Enhanced interleukin-18 levels in the peripheral blood of children with coeliac disease
-
- Lettesjö, Helene (författare)
- Department of Gastrointestinal Research, Pharmacia Diagnostics, Uppsala, Sweden,Allmänpediatrisk forskning/Nordvall
-
- Hansson, Tony (författare)
- Uppsala universitet,Pediatrik,Allmänpediatrisk forskning/Nordvall
-
- Bergqvist, Anders (författare)
- Department of Gastrointestinal Research, Pharmacia Diagnostics, Uppsala, Sweden
-
visa fler...
-
- Grönlund, J (författare)
- Department of Paediatrics, University Hospital of Turku, Turku, Finland
-
- Dannaeus, Anders (författare)
- Uppsala universitet,Pediatrik,Allmänpediatrisk forskning/Nordvall
-
visa färre...
-
(creator_code:org_t)
- 2004-12-14
- 2005
- Engelska.
-
Ingår i: Clinical and Experimental Immunology. - : Oxford University Press (OUP). - 0009-9104 .- 1365-2249. ; 139:1, s. 138-143
- Relaterad länk:
-
http://www.ncbi.nlm....
-
visa fler...
-
https://onlinelibrar...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Coeliac disease (CoD) is a small intestinal disorder characterized by villous atrophy, crypt cell hyperplasia and an increased production of T helper cell type 1 (Th1) cytokines. Interleukin (IL)-18 is a pro-inflammatory cytokine that has a crucial role in maintaining the Th1 response. In this study, the serum levels of IL-18 were measured in children with CoD or other gastrointestinal diseases in order to evaluate the possibility of using IL-18 as a disease activity marker. IL-18 levels were higher in samples from CoD patients [median 443 pg/ml (148-885)] compared to healthy controls [median 205 pg/ml (11-379)], P <0.05. In contrast, the levels of IL-18 were not enhanced significantly in the serum from patients with inflammatory bowel disease (IBD) [median 324 pg/ml (207-546)] or in the disease control group [median 303 pg/ml (2-689)]. In CoD patients, after 2 weeks of gluten challenge (GC), serum IL-18 was unchanged [median 268 pg/ml (59-458)] compared to patients on a gluten-free diet [median 220 pg/ml (53-600)], while IL-18 was increased after 12 weeks of GC [median 551 pg/ml (94-952)], P <0.01. The IL-18 levels correlated with IgA anti-transglutaminase antibody levels (rs=0.59, P=0.016) in serum from untreated CoD patients, and IL-18 also followed the degree of small intestinal villous atrophy in 12 out of 19 CoD patients. Our results support the view that serum IL-18 concentrations in children with CoD follow disease activity, suggesting a role for IL-18 in the induction of an inflammatory Th1-response after gluten exposure.
Nyckelord
- Adolescent
- Atrophy
- Biological Markers/blood
- Celiac Disease/*blood/immunology/pathology
- Child
- Child; Preschool
- Diet; Protein-Restricted
- Female
- Gluten/immunology
- Humans
- Immunoglobulin A/blood
- Infant
- Inflammatory Bowel Diseases/blood/immunology
- Interleukin-18/*blood
- Intestine; Small/pathology
- Male
- Retrospective Studies
- Transglutaminases/immunology
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas